MAPT and Alzheimer disease: In the current study, AD-OSA-MS group showed a prominently elevated P-tau 396 level in CSF compared with AD-OSA-M group (Table 3), not only that, after adjusting for confounding factors, the more severe OSA was still associated with higher P-tau 396 level (Figure 3).